A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron

BACKGROUND: Until recently, WHO recommended daily iron supplementation for all pregnant women (60 mg/d iron combined with 400ug/d folic acid) where anaemia rates exceeded 40 %. Recent studies indicate that this may pose a risk to pregnant women. Therefore, there is a need to explore screen-and-treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bah, Amat, Wegmuller, Rita, Cerami, Carla, Kendall, Lindsay, Pasricha, Sant-Rayn, Moore, Sophie E., Prentice, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944263/
https://www.ncbi.nlm.nih.gov/pubmed/27411564
http://dx.doi.org/10.1186/s12884-016-0934-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944263/
https://www.ncbi.nlm.nih.gov/pubmed/27411564
http://dx.doi.org/10.1186/s12884-016-0934-8

Ejemplares similares